Works matching AU Tiu, Ramon V.

Results: 34

Clinicogenomic factors and treatment patterns among patients with advanced non–small cell lung cancer with or without brain metastases in the United States.

Published in:

Oncologist, 2023, v. 28, n. 11, p. e1075, doi. 10.1093/oncolo/oyad170

By:

Smyth, Emily Nash;
John, Jincy;
Tiu, Ramon V;
Willard, Melinda Dale;
Beyrer, Julie Kay;
Bowman, Lee;
Sheffield, Kristin M;
Han, Yimei;
Brastianos, Priscilla K

Publication type:

Article

A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia.

Published in:

Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0427-x

By:

Vadhan-Raj, Saroj;
Abonour, Rafat;
Goldman, Jonathan W.;
Smith, David A.;
Slapak, Christopher A.;
Ilaria Jr., Robert L.;
Tiu, Ramon V.;
Xuejing Wang;
Callies, Sophie;
Joanne Cox;
Tuttle, Jay L.;
Yiu-Keung Lau;
Roeland, Eric J.

Publication type:

Article

Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts.

Published in:

Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 89, doi. 10.1186/s13045-014-0089-x

By:

Visconte, Valeria;
Tabarroki, Ali;
Li Zhang;
Parker, Yvonne;
Hasrouni, Edy;
Mahfouz, Reda;
Isono, Kyoichi;
Koseki, Haruhiko;
Sekeres, Mikkael A.;
Saunthararajah, Yogen;
Barnard, John;
Lindner, Daniel;
Rogers, Heesun J.;
Tiu, Ramon V.

Publication type:

Article

Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts.

Published in:

Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 3, doi. 10.1186/1756-8722-6-81

By:

Talpaz, Moshe;
Paquette, Ronald;
Afrin, Lawrence;
Hamburg, Solomon I.;
Prchal, Josef T.;
Jamieson, Katarzyna;
Terebelo, Howard R.;
Ortega, Gregory L.;
Lyons, Roger M.;
Tiu, Ramon V.;
Winton, Elliott F.;
Natrajan, Kavita;
Odenike, Olatoyosi;
Claxton, David;
Peng, Wei;
O'Neill, Peter;
Erickson-Viitanen, Susan;
Leopold, Lance;
Sandor, Victor;
Levy, Richard S.

Publication type:

Article

Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations.

Published in:

American Journal of Hematology, 2016, v. 91, p. 406, doi. 10.1002/ajh.24306

By:

Hamilton, Betty Ky;
Visconte, Valeria;
Jia, Xuefei;
Tabarroki, Ali;
Makishima, Hideki;
Hasrouni, Edy;
Abounader, Donna;
Kalaycio, Matt;
Sekeres, Mikkael A.;
Sobecks, Ronald;
Duong Liu, Hien;
Bolwell, Brian;
Maciejewski, Jaroslaw P.;
Copelan, Edward;
Tiu, Ramon V.

Publication type:

Article

Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations.

Published in:

American Journal of Hematology, 2016, v. 91, n. 4, p. 406, doi. 10.1002/ajh.24306

By:

Hamilton, Betty Ky;
Visconte, Valeria;
Jia, Xuefei;
Tabarroki, Ali;
Makishima, Hideki;
Hasrouni, Edy;
Abounader, Donna;
Kalaycio, Matt;
Sekeres, Mikkael A.;
Sobecks, Ronald;
Liu, Hien Duong;
Bolwell, Brian;
Maciejewski, Jaroslaw P.;
Copelan, Edward;
Tiu, Ramon V.

Publication type:

Article

Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10).

Published in:

American Journal of Hematology, 2014, v. 89, n. 8, p. 862, doi. 10.1002/ajh.23755

By:

Visconte, Valeria;
Tabarroki, Ali;
Zhang, Li;
Hasrouni, Edy;
Gerace, Chris;
Frum, Robyn;
Ai, Jing;
Advani, Anjali S.;
Duong, Hien K.;
Kalaycio, Matt;
Saunthararajah, Yogen;
Sekeres, Mikkael A.;
His, Eric D.;
Shetty, Shashirekha;
Rogers, Heesun J.;
Tiu, Ramon V.

Publication type:

Article

Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia.

Published in:

American Journal of Hematology, 2014, v. 89, n. 2, p. 168, doi. 10.1002/ajh.23605

By:

Ornstein, Moshe C.;
Mukherjee, Sudipto;
Mohan, Sanjay;
Elson, Paul;
Tiu, Ramon V.;
Saunthararajah, Yogenthiran;
Kendeigh, Cassie;
Advani, Anjali;
Kalaycio, Matt;
Maciejewski, Jaroslaw P.;
Sekeres, Mikkael A.

Publication type:

Article

Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.

Published in:

American Journal of Hematology, 2013, v. 88, n. 10, p. 906, doi. 10.1002/ajh.23530

By:

Wenzell, Candice M.;
Gallagher, Erika M.;
Earl, Marc;
Yeh, Jun-Yen;
Kusick, Karissa N.;
Advani, Anjali S.;
Kalaycio, Matt E.;
Mukherjee, Sudipto;
Tiu, Ramon V.;
Maciejewski, Jaroslaw P.;
Sekeres, Mikkael A.

Publication type:

Article

Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00677-7

By:

Perl, Alexander E.;
Hosono, Naoko;
Montesinos, Pau;
Podoltsev, Nikolai;
Martinelli, Giovanni;
Panoskaltsis, Nicki;
Recher, Christian;
Smith, Catherine C.;
Levis, Mark J.;
Strickland, Stephen;
Röllig, Christoph;
Groß-Langenhoff, Marco;
Chou, Wen-Chien;
Lee, Je-Hwan;
Yokoyama, Hisayuki;
Hasabou, Nahla;
Lu, Qiaoyang;
Tiu, Ramon V.;
Altman, Jessica K.

Publication type:

Article

Concomitant conjunctival mucosa-associated lymphoid tissue lymphoma and small lymphocytic lymphoma associated with immunoglobulin M macroglobulinemia successfully treated with intensity modulated radiation therapy.

Published in:

Leukemia & Lymphoma, 2010, v. 51, n. 5, p. 952, doi. 10.3109/10428191003717738

By:

Tiu, Ramon V.;
Singh, Arun D.;
Workman, Juliann;
Cotta, Claudiu V.;
Sweetenham, John W.

Publication type:

Article

Pak and Rac GTPases promote oncogenic KIT-induced neoplasms.

Published in:

Journal of Clinical Investigation, 2013, v. 123, n. 10, p. 4449, doi. 10.1172/JCI67509

By:

Martin, Holly;
Mali, Raghuveer Singh;
Ma, Peilin;
Chatterjee, Anindya;
Ramdas, Baskar;
Sims, Emily;
Munugalavadla, Veerendra;
Ghosh, Joydeep;
Mattingly, Ray R.;
Visconte, Valeria;
Tiu, Ramon V.;
Vlaar, Cornelis P.;
Dharmawardhane, Suranganie;
Kapur, Reuben

Publication type:

Article

Molecular and phenotypic heterogeneity of refractory anemia with ring sideroblasts associated with marked thrombocytosis.

Published in:

2016

By:

Visconte, Valeria;
Tabarroki, Ali;
Hasrouni, Edy;
Maciejewski, Jaroslaw P.;
Hsi, Eric D.;
Tiu, Ramon V.;
Rogers, Heesun J.

Publication type:

Letter to the Editor

Safe and effective use of ponatinib in a patient with chronic myeloid leukemia and acute venous thromboembolism on therapeutic anti-coagulation.

Published in:

2016

By:

Shomali, William;
Redmond, Cheryl;
Bogati, Samjhana;
Zimmerman, Cassandra;
Visconte, Valeria;
Tabarroki, Ali;
Kalaycio, Matt;
Tiu, Ramon V.

Publication type:

Letter to the Editor

Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 9, p. 2536, doi. 10.3109/10428194.2014.1003557

By:

Ornstein, Moshe C.;
Mukherjee, Sudipto;
Keng, Michael;
Elson, Paul;
Tiu, Ramon V.;
Saunthararajah, Yogenthiran;
Maggiotto, Amanda;
Schaub, Madeline;
Banks, Diane;
Advani, Anjali;
Kalaycio, Matt;
Maciejewski, Jaroslaw P.;
Sekeres, Mikkael A.

Publication type:

Article

ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 6, p. 1881, doi. 10.3109/10428194.2014.974596

By:

Shivarov, Velizar;
Gueorguieva, Ralitza;
Ivanova, Milena;
Tiu, Ramon V.

Publication type:

Article

Screening for SF3B1 mutations is a useful tool to differentiate between acquired clonal and non-clonal sideroblastic anemia.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 6, p. 1888, doi. 10.3109/10428194.2014.976821

By:

Visconte, Valeria;
Tabarroki, Ali;
Gerace, Christopher J.;
Al-Issa, Karam;
Hsi, Eric D.;
Rogers, Heesun J.;
Sekeres, Mikkael A.;
Silver, Bernard J.;
Lichtin, Alan E.;
Mukherjee, Sudipto;
Tiu, Ramon V.

Publication type:

Article

Spontaneous recovery of severe nilotinib-induced bone marrow aplasia and successful retreatment with dasatinib in a patient with Chronic Phase Chronic Myeloid Leukemia.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 3, p. 811, doi. 10.3109/10428194.2014.935367

By:

Estephan, Fayez;
Rogers, Heesun J.;
Visconte, Valeria;
Tabarroki, Ali;
Ai, Jing;
Duong, Hien K.;
Kalaycio, Matt;
Tiu, Ramon V.

Publication type:

Article

Ruxolitinib in combination with DNA methyltransferase inhibitors: clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts.

Published in:

2015

By:

Tabarroki, Ali;
Saunthararajah, Yogen;
Visconte, Valeria;
Cinalli, Tracy;
Colaluca, Kristin;
Rogers, Heesun J.;
Sekeres, Mikkael A.;
Duong, Hien K.;
Stein, Brady L.;
Tiu, Ramon V.

Publication type:

Letter to the Editor

Successful use of very low dose subcutaneous decitabine to treat high-risk myelofibrosis with Sweet syndrome that was refractory to 5-azacitidine.

Published in:

2014

By:

Liu, Yang;
Tabarroki, Ali;
Billings, Steven;
Visconte, Valeria;
Rogers, Heesun J.;
Hasrouni, Edy;
Englehaupt, Ricki;
Kalaycio, Matt;
Sekeres, Mikkael A.;
Saunthararajah, Yogen;
Tiu, Ramon V.

Publication type:

Case Study

Clinical experiences with ruxolitinib in symptomatic patients with myeloproliferative neoplasm with chronic kidney disease.

Published in:

Leukemia & Lymphoma, 2014, v. 55, n. 1, p. 213, doi. 10.3109/10428194.2013.797086

By:

Tabarroki, Ali;
Visconte, Valeria;
Rogers, Heesun J.;
Sekeres, Mikkael A.;
Samaras, Christy;
Lichtin, Alan;
Duong, Hien K.;
Englehaupt, Ricki;
Cinalli, Tracy;
Dodd, Kristin;
Desamito, John;
Rouphail, Basel;
Altman, Jessica K.;
Stein, Brady L.;
Tiu, Ramon V.

Publication type:

Article

The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication?

Published in:

Expert Review of Hematology, 2013, v. 6, n. 1, p. 59, doi. 10.1586/EHM.12.67

By:

Otrock, Zaher K.;
Tiu, Ramon V.;
Maciejewski, Jaroslaw P.;
Sekeres, Mikkael A.

Publication type:

Article

De Novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 266, doi. 10.1111/j.1365-2141.2011.08972.x

By:

Portell, Craig A.;
Sekeres, Mikkael A.;
Rogers, Heesun J.;
Tiu, Ramon V.

Publication type:

Article

Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.

Published in:

British Journal of Haematology, 2009, v. 146, n. 5, p. 479, doi. 10.1111/j.1365-2141.2009.07757.x

By:

Maciejewski, Jaroslaw P.;
Tiu, Ramon V.;
O'Keefe, Christine

Publication type:

Article

A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF).

Published in:

Cancer (0008543X), 2012, v. 118, n. 16, p. 3968, doi. 10.1002/cncr.26741

By:

Bejanyan, Nelli;
Tiu, Ramon V.;
Raza, Azra;
Jankowska, Ania;
Kalaycio, Matt;
Advani, Anjali;
Chan, Josephine;
Saunthararajah, Yogen;
Mooney, Lindsey;
Maciejewski, Jaroslaw P.;
Sekeres, Mikkael A.

Publication type:

Article

Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.

Published in:

Genes, Chromosomes & Cancer, 2010, v. 49, n. 4, p. 390, doi. 10.1002/gcc.20748

By:

Huh, Jungwon;
Tiu, Ramon V.;
Gondek, Lukasz P.;
O'Keefe, Christine L.;
Jasek, Monika;
Makishima, Hideki;
Jankowska, Ania M.;
Jiang, Ying;
Verma, Amit;
Theil, Karl S.;
McDevitt, Michael A.;
Maciejewski, Jaroslaw P.

Publication type:

Article

Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1and CBLMutations Are Present in Systemic Mastocytosis.

Published in:

PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043090

By:

Traina, Fabiola;
Visconte, Valeria;
Jankowska, Anna M.;
Makishima, Hideki;
O'Keefe, Christine L.;
Elson, Paul;
Yingchun Han;
Hsieh, Fred H.;
Sekeres, Mikkael A.;
Mali, Raghuveer Singh;
Kalaycio, Matt;
Lichtin, Alan E.;
Advani, Anjali S.;
Duong, Hien K.;
Copelan, Edward;
Kapur, Reuben;
Saad, Sara T. Olalla;
Maciejewski, Jaroslaw P.;
Tiu, Ramon V.;
Moura, Ivan Cruz

Publication type:

Article

Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation.

Published in:

2014

By:

Mukherjee, Sudipto;
Reddy, Chandana A;
Ciezki, Jay P;
Abdel-Wahab, May;
Tiu, Ramon V;
Copelan, Edward;
Advani, Anjali A;
Saunthararajah, Yogen;
Paulic, Katarina;
Hobson, Sean;
Maciejewski, Jaroslaw P;
Bolwell, Brian J;
Kalaycio, Matt;
Dreicer, Robert;
Klein, Eric A;
Sekeres, Mikkael A

Publication type:

Journal Article

Risk for Developing Myelodysplastic Syndromes in Prostate Cancer Patients DefinitivelyTreated With Radiation.

Published in:

JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 3, p. 1, doi. 10.1093/jnci/djt462

By:

Mukherjee, Sudipto;
Reddy, Chandana A.;
Ciezki, Jay R.;
Abdel-Wahab, May;
Tiu, Ramon V.;
Copelan, Edward;
Advani, Anjali A.;
Saunthararajah, Yogen;
Paulic, Katarina;
Hobson, Sean;
Maciejewski, Jaroslaw R.;
Bolwell, Brian J.;
Kalaycio, Matt;
Dreicer, Robert;
Klein, Eric A.;
Sekeres, Mikkael A.

Publication type:

Article

Practical management of patients with chronic myeloid leukemia who develop tyrosine kinase inhibitor-resistant BCR-ABL1 mutations.

Published in:

Therapeutic Advances in Hematology, 2014, v. 5, n. 4, p. 107, doi. 10.1177/2040620714537865

By:

Jing Ai;
Tiu, Ramon V.

Publication type:

Article

AML-162: Efficacy and Safety of Venetoclax in Combination with Gilteritinib for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: Updated Analyses of a Phase 1b Study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S285, doi. 10.1016/S2152-2650(21)01684-0

By:

Altman, Jessica K.;
Daver, Naval;
Maly, Joseph;
Levis, Mark;
Ritchie, Ellen;
Litzow, Mark;
McCloskey, James;
Smith, Catherine C.;
Schiller, Gary;
Bradley, Terrence;
Tiu, Ramon V.;
Naqvi, Kiran;
Siddani, Satya;
Jing Wang;
Lee, Paul;
Perl, Alexander E.

Publication type:

Article

AML-091: Clinical Outcomes in Patients with Relapsed/Refractory Acute Myeloid Leukemia Treated with Gilteritinib Who Received Prior Midostaurin or Sorafenib.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S280, doi. 10.1016/S2152-2650(21)01674-8

By:

Perl, Alexander E.;
Altman, Jessica K.;
Hosono, Naoko;
Montesinos, Pau;
Podoltsev, Nikolai;
Martinelli, Giovanni;
Smith, Catherine C.;
Levis, Mark J.;
Röllig, Christoph;
Groß-Langenhoff, Marco;
Hasabou, Nahla;
Qiaoyang Lu;
Tiu, Ramon V.

Publication type:

Article

Poster: AML-162: Efficacy and Safety of Venetoclax in Combination with Gilteritinib for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: Updated Analyses of a Phase 1b Study.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S212, doi. 10.1016/S2152-2650(21)01329-X

By:

Altman, Jessica K.;
Daver, Naval;
Maly, Joseph;
Levis, Mark;
Ritchie, Ellen;
Litzow, Mark;
McCloskey, James;
Smith, Catherine C.;
Schiller, Gary;
Bradley, Terrence;
Tiu, Ramon V.;
Naqvi, Kiran;
Siddani, Satya;
Wang, Jing;
Lee, Paul;
Perl, Alexander E.

Publication type:

Article

Poster: AML-091: Clinical Outcomes in Patients with Relapsed/Refractory Acute Myeloid Leukemia Treated with Gilteritinib Who Received Prior Midostaurin or Sorafenib.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S210, doi. 10.1016/S2152-2650(21)01314-8

By:

Perl, Alexander E;
Altman, Jessica K;
Hosono, Naoko;
Montesinos, Pau;
Podoltsev, Nikolai;
Martinelli, Giovanni;
Smith, Catherine C;
Levis, Mark J;
Röllig, Christoph;
Groß-Langenhoff, Marco;
Hasabou, Nahla;
Lu, Qiaoyang;
Tiu, Ramon V

Publication type:

Article